MedTech Spectrum

Article Name Medtech

Leading U.S. Cancer Center Selects Sectra for Integrated Diagnostics and Enhanced Patient Care

Adoption of Sectra's enterprise imaging solution aims to streamline workflows and boost collaboration in oncology diagnostics.

30th April, 2025

Avant Technologies and Ainnova Request FDA Pre-Submission Meeting for VisionAI Platform

Companies seek guidance on clinical trial design for AI-driven diabetic retinopathy detection, aiming for 510(k) clearance to enter U.S. market.

30th April, 2025

Nature Communications Medicine Publishes Positive Data for Lenire® Tinnitus Device

Retrospective study from Alaska Hearing & Tinnitus Center shows 91.5% responder rate and significant improvement in Tinnitus Handicap Inventory scores after 12 weeks of treatment.

29th April, 2025

TheraLight Introduces the New TheraLight FIT

Compact design and standard voltage compatibility bring professional-grade photobiomodulation therapy to more wellness centers and clinics nationwide.

29th April, 2025

HeartcoR Partners with Wellysis to Offer S-Patch Wearable ECG for Clinical TrialsHeartcoR Partners with Wellysis to Offer S-Patch Wearable ECG for Clinical Trials

This milestone partnership supports the mission of both organizations to improve clinical trials through advanced medical technology.

29th April, 2025

Healthy.io Acquires Labrador Health

Advancing the Future of At-Home Kidney Diagnostics

29th April, 2025

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent

29th April, 2025

Olympus Appoints New CEO

Names Bob White Representative Executive Officer, President, Chief Executive Officer and a new Director candidate

29th April, 2025

Medtronic's OmniaSecure™ Defibrillation Lead Receives FDA Approval for Right Ventricular Use

Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle

28th April, 2025

CIRCA Scientific's PeriCross™ Epicardial Access Kit Receives FDA 510(k) Clearance

CIRCA Scientific receives FDA 510(k) clearance for the PeriCross™ Epicardial Access Kit, a novel tine-based system designed to support controlled and efficient subxiphoid access to the pericardial space.

25th April, 2025

Dr. Kingsley R. Chin and KIC Ventures Celebrate 25 Years of Surgeon-Led Innovation

From the OR to the boardroom, a growing wave of entrepreneurial physicians is reshaping the future of spine surgery and healthcare innovation

25th April, 2025

Center for Better Aging Extends Chicago Testing, Diagnostic Access

St. Bernard Hospital CT/Mammography Suite Addresses South Side's Health Risks

24th April, 2025

Baebies Receives FDA Breakthrough Device Designation for First Point-of-Care Heparin Monitoring Test

FINDER® platform enables rapid, low-volume Anti-Factor Xa testing, transforming anticoagulation care at the bedside.

24th April, 2025

BD Launches First-of-its-Kind Bioabsorbable Mesh for Umbilical Hernia Repair

Innovative mesh aims to improve patient outcomes by naturally absorbing into the body post-surgery.

24th April, 2025

Clarivate Unveils DRG Commercial Analytics 360 for Medtech

New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations

23rd April, 2025

Theranica's Nerivio® Wearable Migraine Device Secures Coverage from Major U.S. Health Insurer

The policy expands access to this effective, non-drug treatment for members as young as 8 years old who are diagnosed with migraine

23rd April, 2025

Laxco Launches Accuva LEAP – Next-Gen Imaging System for Advanced Research

The innovative platform sets a new benchmark in high-resolution imaging tailored for cutting-edge scientific exploration.

23rd April, 2025

USA: Minder® Becomes First FDA-Approved Implantable Continuous EEG MonitorUSA: Minder® Becomes First FDA-Approved Implantable Continuous EEG Monitor

The FDA has granted authorisation for Minder under its De Novo pathway creating a new classification of device, allowing for marketing and sale of the device in the US for patients with drug resistant epilepsy

23rd April, 2025